BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9307238)

  • 1. Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides.
    Wirguin I; Briani C; Suturkova-Milosevic L; Fisher T; Della-Latta P; Chalif P; Latov N
    J Neuroimmunol; 1997 Sep; 78(1-2):138-42. PubMed ID: 9307238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni.
    Lee G; Jeong Y; Wirguin I; Hays AP; Willison HJ; Latov N
    J Neuroimmunol; 2004 Jan; 146(1-2):63-75. PubMed ID: 14698848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
    Gregson NA; Rees JH; Hughes RA
    J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
    Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of conduction block by Campylobacter jejuni lipopolysaccharides and focal neural insult.
    Ifergane G; Bersudsky M; Kachko L; Wirguin I
    J Neurol Sci; 2003 Sep; 213(1-2):11-4. PubMed ID: 12873748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunopathological evidence of terminal residues containing sialic acid in Campylobacter jejuni lipopolysaccharide as the critical antigen to induce peripheral neuropathy].
    Xiang SL; Cai FC; Zhang XP; Deng B
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):665-70. PubMed ID: 16191299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
    Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
    J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside.
    Prendergast MM; Lastovica AJ; Moran AP
    Infect Immun; 1998 Aug; 66(8):3649-55. PubMed ID: 9673245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.
    Wirguin I; Suturkova-Milosevic L; Della-Latta P; Fisher T; Brown RH; Latov N
    Ann Neurol; 1994 Jun; 35(6):698-703. PubMed ID: 8210226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Prendergast MM; Willison HJ; Moran AP
    Infect Immun; 1999 Jul; 67(7):3698-701. PubMed ID: 10377164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Yuki N; Ichihashi Y; Taki T
    J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
    Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
    Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
    Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M; Yuki N; Hirata K
    J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Neisser A; Schwerer B; Bernheimer H; Moran AP
    J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.
    Ang CW; Dijkstra JR; de Klerk MA; Endtz HP; van Doorn PA; Jacobs BC; Jeurissen SH; Wagenaar JA
    PLoS One; 2010 Mar; 5(3):e9820. PubMed ID: 20339556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex of GM1- and GD1a-like lipo-oligosaccharide mimics GM1b, inducing anti-GM1b antibodies.
    Koga M; Gilbert M; Li J; Yuki N
    PLoS One; 2015; 10(4):e0124004. PubMed ID: 25867522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.